Keyword: Allergan

Merz, going for a strong customer focus, recently did something many of its pharma peers have done: split into distinct operating businesses.

AbbVie is plotting a $28 billion bond sale to help fund its massive Allergan buyout, Bloomberg reports, the fourth largest in history.

While forthcoming migraine meds from Eli Lilly, Allergan and Biohaven do beat placebo, they're not much better than existing triptan drugs, ICER says.

Hey, AbbVie: Botox may be a long-term winner, but not every drug in Allergan's stable is shining quite so brightly. 

The suit alleged Allergan tried to pull Namenda off the market right before patent expiration to force patients onto its long-acting version.

Allergan’s new campaign “My Glaucoma” looks to raise awareness of the seriousness of the disease and uses real patients and caregivers.

Allergan is backing the Aesthetic Society's development of an app for breast implant patients to store records and track safety.

On the heels of settling an opioid bellwether case, both Teva and Johnson & Johnson are working on a "framework" deal to escape thousands of suits.